A new market study, “ Global Biotechnology Market, - Global Market Analysis, Trends and Opportunities 2020 - 2025” has been featured on WiseGuyReports.
Biotechnology industry covers the study of living organisms to develop or modify new products for a specific purpose. Increasing research and development activities coupled with rising investment by key players in this market is driving the market growth significantly. Furthermore, the growth is attributed to the favorable government initiatives to promote biotech field across the globe. As per the various research publications, currently, more than 250 biotechnology vaccines and products are commercially available and is projected to increase at a significant rate. On contrary, the high cost of biopharmaceuticals coupled with the strict regulatory environment has been acknowledged as a major restraining factor for this industry
Technology Takeaway
In terms of technology, the global biotechnology market is categorized as PCR, NanoBiotechnology, DNA Sequencing, Fermentation, Tissue Regeneration, Cell-Based Assay, and others. Of which, tissue regeneration segment achieved the highest share of the total market, accounted for more than USD 75 billion in 2019. It refers to the method of combining biological active molecule with scaffold/cells into functional tissue. Tissue engineering and regeneration exhibit strong potential in the skeletal reconstruction of large bone defects as well as gene-based therapies. Cartilage and artificial skin are some of the examples of tissue regeneration and engineered products approved by the U.S. FDA. Currently, several research activities are undergoing to develop high-throughput assays and instruments in order to reduce the complexity, time, and cost of tissue engineering. In addition to medical applications, non-therapeutic applications of this method include tissue chips that can be used to test toxicity and development of biosensors.
COVID-19 Impact and Recovery Analysis
The novel COVID-19 has put the world on a standstill, affecting major operations, leading to an industrial catastrophe. However, the global biotechnology market is positively affected due to this outbreak. This report presented by AnalystView Market Insights contains a thorough analysis of the pre and post COVID-19 market scenarios. The report includes all the recent development and changes recorded during the COVID-19 outbreak and comprehends the analysis of top performer segments and marginal growth segment in biotechnology sector.
Regional Takeaway
Regionally, developed regions such as North America and Europe accounted for the highest share of the global industry. Increasing research and development activities coupled with growing demand for effective pharmaceuticals drive the regional growth. For example, as per the Pharmaceutical Research and Manufacturers Association (PhRMA), the U.S. firms conduct over half of the world’s R&D activities in the pharma sector and hold the intellectual property rights (IPR) on most of the new therapeutics.
GLOBAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY
PCR
NanoBiotechnology
DNA Sequencing
Fermentation
Tissue Regeneration
Cell-Based Assay
Others
GLOBAL BIOTECHNOLOGY MARKET, BY APPLICATION
Bioservices
Biopharmacy
Bioindustrial
Bio-agriculture
GLOBAL BIOTECHNOLOGY MARKET, BY REGION
North America
U.S.
Canada
Europe
Germany
France
Rest of Europe
Asia Pacific
India
China
Rest of APAC
Rest of the World
Middle East and Africa
Latin America
FOR MORE DETAILS : https://www.wiseguyreports.com/reports/5641674-biotechnology-market-by-technology-pcr-nanobiotechnology-dna-sequencing
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +162-825-80070 (US)
Ph: +44 2035002763 (UK)
According to the IMARC Group, Regenerative medicine refers to a field of biomedical sciences involved in restoring the structure and function of damaged cells, organs, and tissues.
It includes the study of stem cells that are developed in laboratories and then safely inserted into the human body to regenerate damaged bones, cartilage, blood vessels, and organs.
Cellular and acellular regenerative medicines are widely adopted in various clinical therapeutic procedures, including cell therapies, immunomodulation, and tissue engineering.
They have the potential to treat various chronic diseases, including Alzheimer's, Parkinson's, cardiovascular disorders (CVDs), osteoporosis, spinal cord injuries, etc.Download PDF Brochure of the “report name” @ https://www.imarcgroup.com/regenerative-medicine-market/requestsampleThe rising prevalence of chronic diseases and genetic disorders is primarily driving the demand for regenerative medicine across the globe.
Moreover, the growing geriatric population who are more prone to musculoskeletal, dermatological, and cardiological disorders is also augmenting the need for regenerative medicines.
Furthermore, several technological advancements in cell-based therapies have led to the adoption of 3D bioprinting techniques and artificial intelligence (AI), thereby further propelling the market for regenerative medicine.
This study involved four major activities in estimating the current size of the biomaterials market.
The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.
Both top-down and bottom-up approaches were employed to estimate the complete market size.According to the new market research report “Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural), Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) – Global Forecast to 2025″, published by MarketsandMarkets™, the global Biomaterials Market is projected to reach USD 47.5 billion by 2025 from USD 35.5 billion in 2020, at a CAGR of 6.0% during the forecast period.Biomaterials market growth is driven mainly by factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases, increasing research on regenerative medicine.
In addition, high growth is expected for plastic surgery and wound healing applications, which will further drive the growth of the biomaterials market in the coming years.Browse in-depth TOC on “Biomaterials Market”333 – Tables47 – Figures298 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=393The Growth in this market is primarily attributed to increasing funds and grants by government bodies and universities for the development of novel biomaterials, increasing demand for implantable devices, growing demand for biomaterials in plastic surgery and wound healing applications, rising incidences of cardiovascular diseases, and rising awareness and research on regenerative medicine.The metallic biomaterials segment accounted for the largest share of the type segment in the market in 2019.On the basis type of materials, the biomaterials market is broadly segmented into Metallic, Polymeric, Ceramic, and Natural biomaterials.
This can primarily be attributed to the wide use of metals in the manufacturing of medical devices used in cardiovascular, dental, and orthopedic applications.The cardiovascular application segment accounted for the largest share of the application segment in the market in 2019.Based on application, the biomaterials market is categorized into seven segments— cardiovascular, orthopedic, ophthalmology, neurological/central nervous system (CNS), dental, tissue engineering, wound healing, plastic surgery, and other applications.
It is also estimated to grow at the highest CAGR in the metallic biomaterials market during the forecast period, this is mainly due to Japan’s growing healthcare industry, increasing geriatric population, rising number of cosmetic and plastic surgeries in India, lucrative medical devices industry, and favorable tax policies in China.Some of the prominent players in the biomaterials market are BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Corbion (Netherlands), Royal DSM (Netherlands), Evonik Industries (Germany), Carpenter Technology Corporation (US), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), CoorsTek Inc. (US), CeramTec (Germany), and GELITA AG (Germany).Browse Adjacent Markets: Biotechnology Market Research Reports & ConsultingBrowse Related Reports:Medical Ceramics Market by Material (Zirconia, Alumina, Hydroxyapatite, Glass, Bioresorbable, Bioinert, Bioactive, Piezoceramics), Application (Dental, Orthopedic, Cardiovascular, Diagnostic, Surgical Implants, Dermal Fillers) – Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/medical-ceramic-market-237425129.htmlDental Bone Graft Substitute Market by Type (Synthetic Bone Grafts, Xenograft, Allograft, Alloplast), Application (Sinus Lift, Ridge Augmentation, Socket Preservation), Product (Bio-OSS, OsteoGraf, Grafton), End User (Hospital)- Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/dental-bone-graft-substitutes-market-159678690.htmlAbout MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.
The report “Top 10 Cellular Analysis Market by Technology (Imaging, PCR, Flow Cytometry, High-content Screening, Blotting, Spectrophotometry), Application (Stem Cell, Cancer, Tissue Engineering) & End User (Biotechnology, Research) – Global Forecast to 2021″, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the top 10 cellular analysis market along with the estimates and forecasts of the revenue and market share analysis.Ask for PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247924081The top 10 cellular analysis market is expected to reach USD 41.34 Billion by 2021 from USD 28.66 Billion in 2016, at a CAGR of 7.6% from 2016 to 2021.
The major factors driving the growth of this market are the growing biotechnology and biopharmaceutical industries, introduction of technologically advanced cell analysis instruments, increasing incidence of infectious and chronic diseases and rising number of patients suffering from cancer, and increasing investments from various government associations & life sciences companies for cell biology research activities.This report segments the top 10 cellular analysis market on the basis of technology, application, end user, and region.
Based on technology, the top 10 cellular analysis market is segmented into cell imaging techniques, polymerase chain reaction (PCR), flow cytometry, cell counting, spectrophotometry, blotting, high-content screening, cell microarray, sample preparation technologies, and centrifugation.
The cell imaging techniques segment is expected to dominate the top 10 cellular analysis market in 2016.
The increasing number of cancer cases, rising investments in cell biology research, and introduction of technologically advanced cell imaging instruments for the morphological & anatomical examination of specific or group of cells are factors contributing to the growth of this segment.On the basis of application, the top 10 cellular analysis market is segmented into biopharmaceutical applications, stem cell research, cancer research, instruments, tissue engineering & regenerative medicine, and other applications (in vitro diagnostics, organ cultures, virology, IVF, and genetic counselling).
The biopharmaceutical application segment is expected to account for the largest share of the top 10 cellular analysis market in 2016.
Moreover, direct digital manufacturing, the expiry of key patents in the coming years, and the growing demand for organ transplant provide significant growth opportunities in the industry.
However, stringent regulatory process and the dearth of trained professionals may hinder the growth of this market.The overall 3D printing medical devices industry is witnessing a new phase of technological developments, with the launch of technologically advanced products.
In June 2017, 3D Systems (US) launched the Simbionix SPINE Mentor, a hands-on simulated training tool for minimally invasive surgical procedures.
The Simbionix SPINE Mentor is a combination of medical tools and 3D printing to develop hybrid spinal surgery training solutions.
Moreover, companies are also focusing on launching planning systems using 3D printing with the aim to enhance the medical surgery procedures.
Moreover, launching innovative products in the market helps companies gain a competitive advantage and drive the uptake of their products.3D Printing Medical Devices Market Growth Request Free PDF Brochure - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90799911In recent years, there has been a significant increase in public-private funding to support various initiatives in the 3D printing industry.
